Royalty Pharma plc
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various bioph…
Biotechnology
US, New York [HQ]
RPRX/Financial Reporting
Income Statements
7 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,597.00 | 1,794.00 | 1,814.00 | 2,122.00 | 2,289.00 | 2,237.00 | 2,354.00 | |
|
EPS
|
3.42 | 3.89 | 6.42 | 1.32 | 1.15 | 0.10 | 2.54 | |
| Diluted in mil. | 3.42 | 3.89 | 6.42 | 1.32 | 1.15 | 0.10 | 1.88 | |
|
Profit
|
1,597.00 | 1,658.00 | 794.00 | 2,033.00 | 2,266.00 | 2,231.00 | 1,793.00 | |
| Gross Margin | 100.00 | 92.43 | 43.82 | 95.85 | 99.00 | 99.75 | 76.19 | |
| Pre Tax | 1,343.00 | 1,517.00 | 2,461.00 | 1,702.00 | 1,241.00 | 230.00 | 1,700.00 | |
| Profit Margin | 84.06 | 84.57 | 135.67 | 80.21 | 54.21 | 10.28 | 72.20 | |
| ETR | 40.40 | 28.55 | 14.19 | 67.39 | 61.43 | 81.38 | 33.25 | |
| Net | 1,210.00 | 1,377.00 | 2,348.00 | 495.00 | 478.00 | 42.00 | 1,134.00 | |
| Profit Margin | 75.72 | 76.76 | 129.45 | 23.34 | 20.91 | 1.91 | 48.20 | |
| EBITDA | 1,141.00 | 1,413.00 | 2,637.00 | 1,882.00 | 1,482.00 | 983.00 | 1,492.00 | |
| EBITDA Margin | 71.46 | 78.76 | 145.37 | 88.69 | 64.73 | 43.95 | 63.37 | |
| Operating Income | 939.00 | 1,364.00 | 2,623.00 | 1,595.00 | 1,430.00 | 977.00 | 1,492.00 | |
| Operating Margin | 58.81 | 76.02 | 144.59 | 75.16 | 62.49 | 43.69 | 63.37 | |
| Interest Income | 6.00 | 24.00 | 22.00 | 28.00 | 53.00 | 78.00 | 72.00 | |
| Loss | -658.00 | -430.00 | -808.00 | -527.00 | -858.00 | -1,314.00 | -862.00 | |
| Cost of Revenue | - - | -135.00 | -1,019.00 | -88.00 | -22.00 | -5.00 | -560.00 | |
|
Operating Expenses
|
-658.00 | -430.00 | -808.00 | -527.00 | -858.00 | -1,314.00 | -862.00 | |
| R&D | -117.00 | -392.00 | -83.00 | -26.00 | -200.00 | -177.00 | -52.00 | |
| G&A | -106.00 | -61.00 | -103.00 | -182.00 | -182.00 | -227.00 | -249.00 | |
| SG&A | -106.00 | -61.00 | -103.00 | -182.00 | -182.00 | -227.00 | -249.00 | |
| S&M | - - | - - | - - | - - | - - | - - | - - | |
| Depreciation and Amortization | -33.00 | -33.00 | -23.00 | -23.00 | -22.00 | -5.00 | - - | |
| Interest Expenses | -247.00 | -279.00 | -268.00 | -157.00 | -166.00 | -187.00 | -187.00 | |
| Other Expenses | -644.00 | -408.00 | -161.00 | -107.00 | -189.00 | -747.00 | -207.00 | |
|
WA Shares Outstanding
|
354.00 | 354.00 | 365.00 | 375.00 | 414.00 | 437.00 | 447.00 | |
| Diluted | 354.00 | 354.00 | 365.00 | 375.00 | 414.00 | 437.00 | 602.00 |